Compound library
Understand what people are taking.
Browse medicines, supplements, herbs, and health foods. Each profile brings community reports and linked research into one clear view.
Browse medicines, supplements, herbs, and health foods. Each profile brings community reports and linked research into one clear view.
Compound made by gut bacteria from ellagitannins in pomegranate and walnuts, and sold ready-made (for example Mitopure) because not everyone's gut bacteria produce it. Trials show it changes mitochondrial and inflammation markers in people; effects on muscle strength and endurance are mixed, and the two main trials in middle-aged and older adults missed their primary endpoints.
1 of 4 results reported a benefit, from 1 published study.
1 randomised trial, 10 people
These are the figures the studies reported, not a prediction for any one person. Where several studies measured the same thing in the same unit, we show a simple average and say so. Every individual result is listed below.
See every resultCardiovascular health — blood pressure, cholesterol, heart function, and circulation.
Also known as: UA, Mitopure
Every published result for this pair, extracted and audited.
These charts group published studies by what they reported and how they were run — green marks studies that reported a benefit for this pairing. Tiers run from pooled analyses of many trials (strongest) to one-off observational reports.
Direction of reported outcomes for Urolithin A in heart health.
Study designs behind these findings.
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysisWang K, et al. · BMC infectious diseases · 2026PMID 41803812 ↗02Energy Drinks as the Legal Cocaine? A Comparative Review of Cardiac Physiopathological and Histopathological PatternsGhamlouch A, et al. · Cardiovascular toxicology · 2025PMID 41266869 ↗03Evaluating the efficacy of ubiquinol in heart failure patients: a systematic review and meta-analysisQazi SU, et al. · Future cardiology · 2024PMID 39049769 ↗04Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysisTzang CC, et al. · Nutrition journal · 2024PMID 39148075 ↗Be the first to share what you noticed with Urolithin A for heart health. Why counts start empty.
Every measured outcome, one row per finding - numbers exactly as reported.
| Study | Design | n | Duration | Outcome measured | Reported result | Direction |
|---|---|---|---|---|---|---|
| PMID 38415449 2024 | Randomised trial | 10 | two 4- week intervention periods | Echocardiographic measures (LVEF, LVEDD, LVESV, TAPSE) | reported qualitatively | No benefit |
| PMID 38415449 2024 | Randomised trial | 10 | two 4- week intervention periods | Other lipid indices (LDL-C, triglycerides, total cholesterol, VLDL-C) | reported qualitatively (p >0.05) | No benefit |
| PMID 38415449 2024 | Randomised trial | 10 | two 4- week intervention periods | Plasma concentrations of pro-BNP, glucose, and CRP | reported qualitatively (p >0.05) | No benefit |
| PMID 38415449 2024 | Randomised trial | 10 | two 4- week intervention periods | Serum HDL-C levels | +6.46 ± 2.33 mg/dL (p =0.026) | Benefit |